Latest news

Filter by category:

FILTER: ALL CATEGORIESFilter by:

Latest news

11 Jun 2021

G7 summit: an opportunity to conquer the pandemic
As leaders of the world’s wealthiest economies convene in Cornwall, UK, we have a once in a generation moment to build a world better placed to deal with the next pandemic.

Read more

Read article

09 Jun 2021

Vaccine specialists and global health experts selected for CEPI's Scientific Advisory Committee
The group will provide key guidance and recommendations on CEPI’s vaccine R&D programmes and broader outbreak response efforts.

Read more

07 Jun 2021

Conquering COVID-19 and future pandemic threats
Richard Hatchett, CEO of CEPI, discuss how to control COVID-19 and what needs to be done to end pandemics.

Read more

04 Jun 2021

To keep coronavirus at bay, we must create a ‘variant-proof’ world
We remain locked in a deadly race with the virus. We will only win when we have created a “variant-proof” world that can keep a lid on the havoc caused by its troublesome mutations.

Read more

27 May 2021

COVAX Joint Statement: Call to action to equip COVAX to deliver 2 billion doses in 2021
Now more than ever, at the peak of the pandemic, we need ambitious, global solutions.

Read more

26 May 2021

CEPI funds expansion of “mix and match” vaccine study, led by Oxford University
Expanded study will assess the use of mixed COVID-19 vaccine regimens, specifically to include the Moderna and Novavax vaccines

Read more

24 May 2021

CEPI and SK bioscience expand partnership to advance multiple COVID-19 variant vaccines and scale-up manufacturing
CEPI to provide up to US$173.4 million of additional funding to SK bioscience for its COVID-19 vaccine programme.

Read more

20 May 2021

Former Assistant Secretary for Preparedness and Response Dr Nicole Lurie appointed US Director at CEPI, the global partnership to develop vaccines to stop future epidemics
Dr Lurie to lead CEPI’s work in the US and strengthen CEPI’s collaboration with the USA

Read more

Read article

19 May 2021

Survey launched by CEPI to track multinational vaccine manufacturing capacity for use in future epidemics and pandemics
The landscaping exercise aims to build the first of-its-kind map tracking cross-regional vaccine production capabilities. 

Read more

14 May 2021

COVAX Manufacturing Task Force to tackle vaccine supply challenges
COVAX has set up a “Manufacturing Task Force” to identify and resolve issues impeding equitable access to vaccines through COVAX.

Read more

14 May 2021

CEPI expands global footprint of its COVID-19 vaccine lab network, and opens testing against Variants of Concern
From July 2021, all COVID-19 vaccine developers are invited to use the network to evaluate their candidate vaccines against SARS-CoV-2 variants.

Read more

©2021 CEPI. All rights reserved

This website uses cookies to improve functionality and performance. If you continue browsing the site, you consent to the use of cookies on this website. For details, see our Cookie Notice.